CISPLATIN NEPHROTOXICITY - A SUMMARY OF PREVENTATIVE INTERVENTIONS

被引：33
作者：
FINLEY, RS [1 ]
FORTNER, CL [1 ]
GROVE, WR [1 ]
机构：
[1] NCI,DCT,CTEP,INVEST DRUG BRANCH,DRUG MANAGEMENT & AUTHORIZAT SECT,BETHESDA,MD 20205
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 05期
关键词：
D O I：
10.1177/106002808501900505
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：362 / 367
页数：6
相关论文
共 47 条
[11]  
GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO
[12]  
2-N
[13]  
HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO
[14]  
2-J
[15]   INTRAPERITONEAL CISPLATIN WITH SYSTEMIC THIOSULFATE PROTECTION [J].
HOWELL, SB ;
PFEIFLE, CL ;
WUNG, WE ;
OLSHEN, RA ;
LUCAS, WE ;
YON, JL ;
GREEN, M .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :845-851
[16]  
HOWELL SB, 1980, CANCER TREAT REP, V64, P611
[17]   THE CLINICAL-APPLICATION OF CHRONOBIOLOGY TO ONCOLOGY [J].
HRUSHESKY, WJM .
AMERICAN JOURNAL OF ANATOMY, 1983, 168 (04) :519-542
[18]  
HRUSHESKY WJM, 1983, P AM SOC CLIN ONCOL, V3, P27
[19]  
KOVACH JS, 1973, CANCER CHEMOTH REP 1, V57, P357
[20]  
LEGHA S, 1984, P AN M AM SOC CLIN, V3, P37
12345